Artificial intelligence helps predict relapse of patients recovered from a heart attack or angina

by Hospital Universitari de Bellvitge

3 years ago
artificial intelligence, myocardial infarction, angina

New artificial intelligence tools will permit to predict the options that a person who has suffered a myocardial infarction or angina will die or suffer a new serious episode during the year after dis...

MARLIT, an artificial intelligence-based app to study floating marine macro-litter

by Universitat de Barcelona

3 years ago
ecosystems, MARLIT, artificial intelligence, macro-litter, oceans

Floating sea macro-litter is a threat to the conservation of marine ecosystems worldwide. The largest density of floating litter is in the great ocean gyres –systems of circular currents that spin a...

La Vanguardia published a press release: 'The future of biotechnology: lower-cost treatments in a short period of time'

by Som Biotech

3 years ago
Central Nervous System, La Vanguardia, biotechnology, Artificial Intelligence, rare diseases

SOM Biotech has designed a computational Artificial Intelligence-based method to analyze molecular structures and select the best option after performing more than 2.5 million comparisons in each p...

Updates on the Ongoing guidance development within MDCG Subgroups

by Asphalion

4 years ago
MDCG, guidance, artificial intelligence, antibody tests, medical devices, MDR

Now that the year is about to come to an end, the European Commission has updated the information on the MDCG’s work in progress, indicating the planning for the endorsement of the guidance document...

SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2

by Som Biotech

4 years ago
respiratory disease, Eravacycline, drug, SARS-CoV-2, SOMAIPRO, IDWeek 2020, artificial intelligence

SOM Biotech announces today that it will present in silico and in vitro results regarding Eravacycline for the treatment of SARS-CoV-2 during a virtual poster presentation at the IDWeek 2020.

Dr. Scott Boyer joins Chemotargets as new CEO

by GENESIS Biomed

4 years ago
Dr. Scott Boyer, Chemotargets, Klaria, AstraZeneca, Pfizer, artificial intelligence, drugs, CLARITY, CREA Inversión

With the new incorporation, the company consolidates its transition from a software business to an AI-driven biotech

EuCanImage: Next-generation artificial intelligence in oncology

by Fundació Bosch i Gimpera

4 years ago
colorectal cancer, UB, precision medicine, artificial intelligence, oncology, EuCanImage

EuCanImage has been launched. This project from the Horizon 2020 program is coordinated by Karim Lekadir, Ramón y Cajal postdoctoral researcher at the Faculty of Mathematics and Computer Science of t...

AI for biopharmaceutical production – Sartorius a new shareholder in DFKI, the German Research Center for Artificial Intelligence

by Sartorius Stedim Spain

4 years ago
medicine, biopharmaceutical, Artificial Intelligence, DFKI, pharma

Sartorius has joined the group of shareholders of the German Research Center for Artificial Intelligence (DFKI). The Göttingen-based life science group and DFKI have already been working together for...

Asabys invests in Israeli MedTech firm Medasense

by CataloniaBio

4 years ago
anaesthesia, Asabys, Medasense Biometrics, artificial intelligence, Medtronic

Asabys Partners, a venture capital firm and member of CataloniaBio & HealthTech, has participated in Medasense Biometrics Ltd’s €15.2-million Series C round of funding along with investors such as...

Telemedicine, a growing trend

by Alma Medical Imaging

4 years ago
patients, health, artificial intelligence, telemedicine

Technology has burst into medicine: artificial intelligence and other digital tools have already proven their usefulness in this field. But, without a doubt, we cannot talk about medical technology wi...

Artificial intelligence, a new tool against leukemia

by Hospital Universitari de Bellvitge

4 years ago
artificial intelligence, leukemia, La Caixa

Dr. Carolina M. Florian project has been selected by La Caixa Health Research grants

Exheus, a new spin-off that analyzes gene expression, using artificial intelligence, to optimize performance, health and nutrition

by Hospital de la Santa Creu i Sant Pau

4 years ago
Exheus, gene, Artificial Intelligence, health, nutrition

Exheus is a recent spin-off born thanks to the research carried out by the Sant Pau Research Institute, the Polytechnic University of Catalonia – BarcelonaTech (UPC) and the company Summit SL, which...